NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Epimede

Epimede

Overview

A privately-held investment company structured as a private fund (PRICAF under Belgian law) that takes long-term positions in innovative life sciences and engineering companies. It focuses on early-stage and growth-stage technological SMEs, primarily located in Wallonia, Belgium.

Portfolio Companies

6

Investments

Epimede investments
CompanyDateStageLead
Wishbone BiotechDec 2021Early FundingCo-investor
RadiomicsNov 2021Series ALead
ImcyseFeb 2021Series B ExtensionCo-investor
Endo Tools TherapeuticsJan 2021Series DCo-investor
ImcyseJun 2019Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLiège
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.